Syringaresinol (SYR) improved cardiac function and alleviated myocardial injury in sepsis-induced cardiac dysfunction mouse via the estrogen receptor (ER)/SIRT1/NLRP3/GSDMD pathway (99). The gene discussed is GSDMD; the disease is Sepsis.